RETENTION AGREEMENTRetention Agreement • July 1st, 2009 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances • California
This Retention Agreement (this “Agreement”) between Monogram Biosciences, Inc. a Delaware corporation (the “Company”) and (“Employee”) is made as of June 30, 2009 by and between the Company and Employee. This Agreement shall be effective as of the Effective Date (defined below).
Laboratory Corporation of America® Holdings 430 South Spring Street Burlington, North Carolina 27215 Telephone: 336-229-1127Monogram Biosciences, Inc. • July 1st, 2009 • In vitro & in vivo diagnostic substances • California
In order to facilitate the consideration and negotiation of a possible negotiated transaction involving Laboratory Corporation of America Holdings (“LabCorp”) and Monogram Biosciences, Inc. (the “Company”), each party (each a “Recipient”) may receive access to certain non-public information regarding the other party (each a “Discloser”) and its subsidiaries. This letter agreement sets forth the Recipient’s obligations regarding the use and disclosure of such information and regarding various related matters. As used herein, each reference to “Recipient” or “Discloser” shall be deemed to apply to both parties.
July 1, 2009 Dear Monogram Biosciences, Inc. Stockholder:Merger Agreement • July 1st, 2009 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances
We are pleased to inform you that on June 22, 2009, Monogram Biosciences, Inc. (“Monogram”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Laboratory Corporation of America Holdings (“LabCorp”) and Mastiff Acquisition Corp., a wholly-owned subsidiary of LabCorp (“Purchaser”).
